MX2008001643A - Metodo para conservar la funcion de celulas productoras de insulina. - Google Patents

Metodo para conservar la funcion de celulas productoras de insulina.

Info

Publication number
MX2008001643A
MX2008001643A MX2008001643A MX2008001643A MX2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A
Authority
MX
Mexico
Prior art keywords
insulin
producing cells
preserving
function
furthering
Prior art date
Application number
MX2008001643A
Other languages
English (en)
Inventor
Wayman Wendell Cheatham
David C Diamond
Anders Hasager Boss
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of MX2008001643A publication Critical patent/MX2008001643A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Se proporciona metodos y composiciones para conservar la funcion de las celulas productoras de insulina y para alargar el periodo de vida de las celulas productoras de insulina en pacientes no dependientes de insulina con trastornos relacionados con la insulina.
MX2008001643A 2005-08-01 2006-08-01 Metodo para conservar la funcion de celulas productoras de insulina. MX2008001643A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70429505P 2005-08-01 2005-08-01
PCT/US2006/030014 WO2007016600A2 (en) 2005-08-01 2006-08-01 Method of preserving the function of insulin-producing cells

Publications (1)

Publication Number Publication Date
MX2008001643A true MX2008001643A (es) 2008-04-07

Family

ID=37561086

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001643A MX2008001643A (es) 2005-08-01 2006-08-01 Metodo para conservar la funcion de celulas productoras de insulina.

Country Status (10)

Country Link
EP (1) EP1915171B1 (es)
JP (2) JP2009503093A (es)
CN (1) CN101232899A (es)
AU (1) AU2006275424B2 (es)
BR (1) BRPI0614489A2 (es)
CA (1) CA2617226A1 (es)
DK (1) DK1915171T3 (es)
ES (1) ES2439455T3 (es)
MX (1) MX2008001643A (es)
WO (1) WO2007016600A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
CN101010305B (zh) 2004-08-20 2010-08-11 曼金德公司 二酮哌嗪合成的催化反应
PL2322180T3 (pl) 2004-08-23 2015-10-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2853268A1 (en) * 2009-01-08 2015-04-01 Mannkind Corporation Treatment of hyperglycemia with GLP-1
AU2010221254B2 (en) * 2009-03-04 2014-04-03 Mannkind Corporation An improved dry powder drug delivery system
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
BRPI1013154B1 (pt) 2009-06-12 2020-04-07 Mannkind Corp Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送系统和方法
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
ES2928365T3 (es) 2013-03-15 2022-11-17 Mannkind Corp Composiciones de dicetopiperazina microcristalina, métodos de preparación y uso del mismo
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
CN105517607A (zh) 2013-08-05 2016-04-20 曼金德公司 吹入设备和方法
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
CN110187123B (zh) * 2019-05-06 2022-07-22 天津医科大学总医院 一种糖尿病早期诊断生物标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132176A0 (en) * 1997-04-02 2001-03-19 Purdue Research Foundation Method for oral delivery of proteins
PT1196430E (pt) * 1999-06-29 2012-04-18 Mannkind Corp Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
AU2004220544B2 (en) * 2003-03-06 2010-06-17 Emisphere Technologies, Inc. Oral insulin therapies and protocol
CN101027082A (zh) * 2004-01-12 2007-08-29 曼恩坎德公司 降低2型糖尿病患者血清胰岛素原水平的方法

Also Published As

Publication number Publication date
JP2015091854A (ja) 2015-05-14
EP1915171A2 (en) 2008-04-30
CN101232899A (zh) 2008-07-30
EP1915171B1 (en) 2013-11-20
AU2006275424A1 (en) 2007-02-08
WO2007016600A2 (en) 2007-02-08
DK1915171T3 (da) 2013-12-09
ES2439455T3 (es) 2014-01-23
BRPI0614489A2 (pt) 2011-03-29
WO2007016600A3 (en) 2007-05-31
JP2009503093A (ja) 2009-01-29
AU2006275424B2 (en) 2013-01-10
CA2617226A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
MX2008001643A (es) Metodo para conservar la funcion de celulas productoras de insulina.
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
WO2007095594A3 (en) Methods and compositions for enhancing engraftment of hematopoietic stem cells
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
MY160041A (en) Compositions and methods for treating parasitic infections
EP2705850A3 (en) Super fast-acting insulin compositions
IL189555A0 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
EP2727998A3 (en) Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
EP1988159A4 (en) CULTURE MEDIUM ADDITIVE FOR ANIMAL CELL FREE SERUM, KIT AND USE OF THE ADDITIVE OR KIT
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
WO2008001240A3 (en) Transdermal delivery of oleocanthal for relief of inflammation
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
EP2048227A3 (en) Methods for proliferating stem cells
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
MX2007012237A (es) Amilina y agonistas de amilina para tratar enfermedades y trastornos siquiatricos.
MX348735B (es) Celulas madre mesenquimales que expresan los receptores tnf-alfa.
MX2008006589A (es) Composiciones de edulcorante natural de mesa, de alta potencia, con perfil temporal y/o de sabor mejorado, metodos para su formulacion, y usos
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
CL2008002227A1 (es) Compuestos derivados de 4-[(8r)-4-amino-5-oxo-7,8-dihidrorimido[5,4-f][1,4]oxazepin-6(5h)-il]fenilo sustituido; su composicion farmaceutica; y uso de los compuestos en el tratamiento de la diabetes de tipo 2, utiles particularmente para tratar la obesidad.
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
MX2007011493A (es) Modalidades antiinflamatorias.
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
WO2008016730A3 (en) Compositions and methods for reducing cellular fat

Legal Events

Date Code Title Description
FA Abandonment or withdrawal